Table 1.
Characteristics of the study population (n = 800).
| Patient Characteristics | Study Cohort (n = 482) | Reference Cohort (n = 318) | ||
|---|---|---|---|---|
| ADR Present | ADR Absent | ADR Present | ADR Absent | |
| Number of patients | 8.5% (41) | 91.5% (441) | 4.1% (13) | 95.9% (305) |
| Age (years), mean ± SD | 50.9 ± 17.8 | 56.4 ± 15.9 | 49.5 ± 17.5 | 49.3 ± 16.6 |
| Gender | ||||
| Male | 78.1% (32) | 66.4% (293) | 53.9% (7) | 64.3% (196) |
| Female | 21.9% (9) | 33.6% (148) | 46.1% (6) | 35.7% (109) |
| Age group | ||||
| 0–10 | - | 0.2% (1) | - | 0.7% (2) |
| 11–20 | 4.9% (2) | 1.4% (6) | 7.7% (1) | 2.3% (7) |
| 21–30 | 12.2% (5) | 6.1% (27) | 7.7% (1) | 12.8% (39) |
| 31–40 | 14.6% (6) | 11.6% (51) | 15.4% (2) | 16.1% (49) |
| 41–50 | 14.6% (6) | 12.9% (57) | 23.1% (3) | 21.3% (65) |
| 51–60 | 19.5% (8) | 22.2% (98) | 7.7% (1) | 18.7% (57) |
| 61–70 | 24.4% (10) | 26.1% (115) | 30.8% (4) | 18.4% (56) |
| 71–80 | 7.3% (3) | 15.6% (69) | 7.7% (1) | 7.9% (24) |
| 81–90 | 2.4% (1) | 3.6% (16) | - | 2.0% (6) |
| 91–100 | - | 0.2% (1) | - | - |
| Duration of hospitalization (days), median (IQR) | 9.0 (15–5) | 5.0 (10–4) | 8.0 (13–6.5) | 6.0 (9–4) |
ADR: adverse drug reaction; IQR: interquartile range.